Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss

Akihito Nakanishi, Noriko Nagase, Hirokazu Kousaki, Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Yuka Morita, Fumiaki Nin · 2026

Read Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss by Akihito Nakanishi, Noriko Nagase, Hirokazu Kousaki, Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Yuka Morita, Fumiaki Nin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353954.txt.

Description

Akihito Nakanishi and eight colleagues test a new way to probe hearing damage. The damage comes from a chemotherapy drug. Their mouse study appeared in PLOS ONE in 2026. The drug, cisplatin, saves lives. But it often costs patients their high-frequency hearing. The team delivered ultrasound through the skull bone. They measured the brain's electrical response. Then they compared shifts in two ranges. One was the bone-conducted ultrasound range. The other was the ordinary hearing range.

Ordinary thresholds worsened clearly after the drug. The ultrasound responses shifted much less. That mismatch carries a warning. The ultrasound route taps a different part of the hearing machinery. It cannot simply stand in for standard tests. Anyone hoping to use it as a quick damage gauge should take note.

Catalog record

CREATORAkihito Nakanishi, Noriko Nagase, Hirokazu Kousaki, Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Yuka Morita, Fumiaki Nin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20039
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0353954

Browse the full library · About the Tower of Babel